Submitted:
02 June 2026
Posted:
03 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Design
2.2. Participants and Sample
2.3. Inclusion and Exclusion Criteria
2.4. Variables and Instrument
2.5. Dimension Score Standardization
2.6. Data Collection
2.7. Data Analysis
2.8. Ethical Considerations
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| AB | Acute Bronchiolitis |
| QR | Quick Response |
| RSV | Respiratory Syncytial Virus |
| SPO2 | Peripherical Oxygen Saturation |
References
- Caballero, M.T.; Polack, F.P.; Stein, R.T. Viral bronchiolitis in young infants: New perspectives for management and treatment. J. Pediatr. (Rio J.) 2017, 93 (Suppl. 1), 75–83. [Google Scholar] [CrossRef] [PubMed]
- Rius-Peris, J.M.; Lucas-García, J.; García-Peris, M.; Escrivá Tomás, P.; Sequí-Canet, J.M.; González de Dios, J. Pandemia por COVID-19 y su repercusión sobre las hospitalizaciones por bronquiolitis en el Centro y Este de España. An. Pediatr. (Barc.) 2021, 95, 345–353. [Google Scholar] [CrossRef] [PubMed]
- Ralston, S.L.; Lieberthal, A.S.; Meissner, H.C.; Alverson, B.K.; Baley, J.E.; Gadomski, A.M.; et al. Clinical practice guideline: The diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014, 134, e1474–e1502. [Google Scholar] [CrossRef] [PubMed]
- Kirolos, A.; Manti, S.; Blacow, R.; Tse, G.; Wilson, T.; Lister, M.; et al. A systematic review of clinical practice guidelines for the diagnosis and management of bronchiolitis. J. Infect. Dis. 2020, 222 (Suppl. 7), S672–S679. [Google Scholar] [CrossRef] [PubMed]
- National Institute for Health and Care Excellence (NICE). Bronchiolitis in Children: Diagnosis and Management; NICE: London, UK, 2021; Available online: https://www.nice.org.uk/guidance/ng9 (accessed on 13 June 2024).
- Francisco, L.; Cruz-Cañete, M.; Pérez, C.; Couceiro, J.A.; Otheo, E.; Launes, C.; et al. Nirsevimab for the prevention of respiratory syncytial virus disease in children. An. Pediatr. (Engl. Ed.) 2023, 99, 257–263. [Google Scholar] [CrossRef] [PubMed]
- Delgado-Castillejo, E.; Carratalá-Tejada, M.; Molina-Rueda, F. Design and reliability study of a parental knowledge, attitude, and practice questionnaire on prevention and management of acute bronchiolitis of children under two years of age. An. Sist. Sanit. Navar. 2023, 46, e1032. [Google Scholar] [CrossRef] [PubMed]
- Cantarero-Arévalo, L.; Hallas, M.P.; Hansen, E.H. Parental knowledge of antibiotic use in children with respiratory infections: A systematic review. Int. J. Pharm. Pract. 2017, 25, 31–49. [Google Scholar] [CrossRef] [PubMed]
- Al Hashmi, A.S.; Al Zakwani, I.; Al Mahruqi, G.; Al Maskari, N.; Al Balushi, Z. Parental knowledge, attitudes and practices regarding antibiotic use for upper respiratory tract infections in children. J. Multidiscip. Healthc. 2021, 14, 1123–1132. [Google Scholar] [CrossRef] [PubMed]
- Campbell, A.; Hartling, L.; Louie-Poon, S.; Scott, S.D. Parent experiences caring for a child with bronchiolitis: A qualitative study. J. Patient Exp. 2020, 7, 1362–1368. [Google Scholar] [CrossRef] [PubMed]
- Albayrak, A.; Colak, D.; Albayrak, R. Evaluation of parental knowledge, attitudes and practices regarding antibiotic use in acute upper respiratory tract infections in children. BMC Pediatr. 2021, 21, 553. [Google Scholar] [CrossRef] [PubMed]
- Friedman, J.N.; Rieder, M.J.; Walton, J.M.; Canadian Paediatric Society. Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months. Paediatr. Child Health 2014, 19, 485–491. [Google Scholar] [CrossRef] [PubMed]
- Bermúdez Barrezueta, L.; Miñambres Rodríguez, M.; Palomares Cardador, M.; Torres Ballester, I.; López Casillas, P.; Moreno Carrasco, J.; et al. Efecto de la exposición prenatal y posnatal al tabaco en el desarrollo de bronquiolitis aguda durante los dos primeros años de vida. An. Pediatr. (Barc.) 2021, 94, 385–395. [Google Scholar] [CrossRef]
- Chiappini, E.; Parretti, A.; Becherucci, P.; Pierattelli, M.; Bonsignori, F.; Galli, L.; et al. Parental and medical knowledge and management of fever in Italian pre-school children. BMC Pediatr. 2012, 12, 97. [Google Scholar] [CrossRef] [PubMed]
- Hersh, A.L.; Jackson, M.A.; Hicks, L.A.; American Academy of Pediatrics Committee on Infectious Diseases. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 2013, 132, 1146–1154. [Google Scholar] [CrossRef] [PubMed]
- Montejo Fernández, M.; Benito Manrique, I.; Montiel Eguía, A.; Benito Fernández, J. Una iniciativa para reducir el uso de medicación innecesaria en lactantes con bronquiolitis en atención primaria. An. Pediatr. (Barc.) 2019, 90, 19–25. [Google Scholar] [CrossRef] [PubMed]
- Lee Mortensen, G.; Harrod-Lui, K. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies. Expert Rev. Vaccines 2022, 21, 1523–1531. [Google Scholar] [CrossRef] [PubMed]
- Gates, M.; Shulhan-Kilroy, J.; Featherstone, R.; MacGregor, T.; Scott, S.D.; Hartling, L. Parent experiences and information needs related to bronchiolitis: A mixed studies systematic review. Patient Educ. Couns. 2019, 102, 864–878. [Google Scholar] [CrossRef] [PubMed]
- Florin, T.A.; Plint, A.C.; Zorc, J.J. Viral bronchiolitis. Lancet 2017, 389, 211–224. [Google Scholar] [CrossRef] [PubMed]
- Coyne, I.; Hallström, I.; Söderbäck, M. Reframing the focus from a family-centred to a child-centred care approach for children’s healthcare. J. Child Health Care 2016, 20, 494–502. [Google Scholar] [CrossRef] [PubMed]
| Variables | Mean (SD) | 95% CI | n(%) | |
| Parente age (years) | 32.13 (10.29) | 30.53 to 33.73 | ||
| Infant age (months) | 9.67 (6.81) | 8.62 to 10.73 | ||
| Number of children | 1.58 (0.81) | 1.46 to 1.71 | ||
| Parent sex | Female | 121 (74.7) | ||
| Male | 40 (24.7) | |||
| Prefer not to answer | 1 (0.6) | |||
| Infant sex | Girl | 73 (45.1) | ||
| Boy | 85 (52.5) | |||
| Prefer not to answer | 4 (2.5) | |||
| Educational level | No formal education | 6 (3.7) | ||
| Primary education | 20 (12.3) | |||
| Secondary education | 43 (26.5) | |||
| Vocational training | 60 (37.0) | |||
| University education | 33 (20.4) | |||
| Previous children with bronchiolitis | No | 119 (73.5) | ||
| Yes | 43 (26.5) | |||
| Bronchiolitis in the current infant | No | 102 (63.0) | ||
| Yes | 60 (37.0) | |||
| Hospitalization due to bronchiolitis | No | 118 (72.8) | ||
| Yes | 44 (27.2) | |||
| Items | Mean (SD) | 95% CI |
| Dimension 1. Risk factors | 12.20 (3.14) | 11.71 to 12.68 |
| 1. I consider exposure to tobacco smoke a risk factor for bronchiolitis | 1.44 (0.69) | 1.33 to 1.55 |
| 2. I consider lack of breastfeeding a risk factor for bronchiolitis | 2.91 (1.19) | 2.73 to 3.10 |
| 3. I consider that living with siblings may affect my child’s respiratory health | 3.59 (1.24) | 3.40 to 3.79 |
| 4. I consider that attending daycare may influence my child’s respiratory health | 2.73 (1.21) | 2.55 to 2.92 |
| 5. I consider it important to seek information from health sources to manage a respiratory infection | 1.52 (0.71) | 1.41 to 1.63 |
| Dimension 2. Signs and symptoms | 15.12 (4.35) | 14.44 to 15.79 |
| 6. I believe I could identify nasal flaring if it appeared | 2.20 (0.92) | 2.05 to 2.34 |
| 7. I believe I could identify chest retractions | 2.19 (1.01) | 2.03 to 2.34 |
| 8. I believe I could identify cyanosis (bluish lips or nails due to lack of oxygen) | 2.01 (0.90) | 1.87 to 2.15 |
| 9. I believe I could identify lethargy or drowsiness in my child | 1.82 (0.76) | 1.70 to 1.94 |
| 10. I believe I could identify breathing difficulty in my child | 1.71 (0.71) | 1.60 to 1.82 |
| 11. I believe I could recognize when food and fluid intake is concerning | 2.11 (0.87) | 1.97 to 2.25 |
| 12. I know the temperature threshold for fever in young children | 1.75 (0.77) | 1.63 to 1.82 |
| 13. If any warning signs appear, I would seek medical care for my child | 1.33 (0.62) | 1.23 to 1.42 |
| Dimension 3. Prevention | 9.17 (3.21) | 8.67 to 9.66 |
| 14. I consider handwashing effective in preventing virus transmission | 1.63 (0.82) | 1.50 to 1.76 |
| 15. I consider covering coughs/sneezes effective in preventing transmission | 1.73 (0.83) | 1.60 to 1.86 |
| 16. I consider limiting visits effective in preventing transmission | 2.12 (0.96) | 1.97 to 2.27 |
| 17. I consider avoiding crowds effective in preventing transmission | 2.01 (0.93) | 1.87 to 2.16 |
| 18. I consider ventilation effective in preventing transmission | 1.68 (0.75) | 1.56 to 1.79 |
| Dimension 4. Care and pharmacological support | 15.68 (4.62) | 14.96 to 16.39 |
| 19. I monitor fluid intake during my child’s respiratory infection | 1.77 (0.76) | 1.65 to 1.89 |
| 20. I adjust feeding during my child’s respiratory infection | 1.77 (0.74) | 1.65 to 1.88 |
| 21. I perform nasal irrigation during respiratory infection | 1.73 (0.71) | 1.62 to 1.85 |
| 22. I would use antipyretics without fever in bronchiolitis | 3.07 (1.36) | 2.86 to 3.28 |
| 23. I would use antibiotics without prescription | 3.90 (1.38) | 3.69 to 4.12 |
| 24. I would use bronchodilators without medical supervision | 3.74 (1.42) | 3.52 to 3.96 |
| 25. I use mucolytics and antitussives for respiratory infections | 2.88 (1.26) | 2.69 to 3.08 |
| Total score (non-normalized) | 52.16 (10.12) | 50.59 to 53.73 |
| Total score (normalized) | −22.84 (10.12) | −24.40 to 21.28 |
| 26. I have taken my child to respiratory physiotherapy sessions | 3.02 (1.32) | 2.82 to 3.23 |
| Dimension | Mean | Post hoc comparisons (p value) |
| Risk factors | 12.20 | vs. Signs and symptoms (<0.001) vs. Prevention (<0.001) vs. Care and pharmacological support (<0.001) |
| Signs and symptoms | 15.12 | vs. Prevention (<0.001) vs. Care and pharmacological support (0.588) |
| Prevention | 9.17 | vs. Care and pharmacological support (<0.001) |
| Care and pharmacological support | 15.68 | — |
| Variable | Dimension | Group | Mean (SD) | p | Effect size | Post hoc(DSCF) |
| Parent sex | Total score | Women (n = 121) | 51.43 (10.419 | 0.037 | ε² = 0.041 | Women vs. Men (p = 0.033) |
| Men (n = 40) | 54.27 (9.08) | |||||
| Prefer not to answer (n = 1) | 56.0 (0.0) | |||||
| Infant sex | Prevention | Boys (n = 73) | 9.82 (3.20) | 0.010 | ε² = 0.058 | Boys vs. Girls (p = 0.071) Boys vs. Prefer not to answer (p = 0.051) Girls vs. Prefer not to answer (p = 0.144) |
| Girls (n = 85) | 8.75 (3.13) | |||||
| Prefer not to answer (n = 4) | 6.0 (2.0) |
| Variables | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| Parent age (1) | — | |||||||
| Infant age (2) | 0.115 (p=0.144) | — | ||||||
| Number of children (3) | 0.161 (p=0.042)* | 0.029 (p=0.713) | — | |||||
| Risk factors (4 ) | −0.145 (p=0.066) | 0.124 (p=0.115) | −0.026 (p=0.744) | — | ||||
| Signs and symptoms (5) | −0.073 (p=0.353) | −0.158 (p=0.045)* | −0.043 (p=0.586) | 0.229 (p=0.003)** | — | |||
| Prevention (6) | −0.037 (p=0.645) | 0.025 (p=0.754) | 0.137 (p=0.086) | 0.210 (p=0.007)** | 0.449 (p<0.001)*** | — | ||
| Care and pharmacological suppor (7) | −0.103 (p=0.192) | −0.171 (p=0.030)* | 0.029 (p=0.714) | −0.010 (p=0.898) | 0.233 (p=0.003)** | 0.208 (p=0.008)** | — | |
| Total score (8) | −0.135 (p=0.087) | −0.075 (p=0.341) | 0.018 (p=0.825) | 0.433 (p<0.001)*** | 0.723 (p<0.001)*** | 0.685 (p<0.001)*** | 0.631 (p<0.001)*** | — |
| Predictor | β(SE) | 95% CI | p | Standardized β |
| Constant | 58.27 (3.20) | 51.94 to 64.60 | <0.001 | — |
| Parent age (years) | −0.09 (0.08) | −0.24 to 0.07 | 0.275 | −0.09 |
| Infant age (months) | −0.14 (0.13) | −0.39 to 0.11 | 0.271 | −0.09 |
| Number of children | 0.00 (1.09) | −2.15 to 2.16 | 0.998 | 0.00 |
| Parent sex | ||||
| Men vs. Women | 2.54 (1.84) | −1.10 to 6.18 | 0.170 | 0.25 |
| Prefer not to answer vs. Women | 0.64 (10.17) | −19.46 to 20.74 | 0.950 | 0.06 |
| Infant sex | ||||
| Girls vs. Child | −2.94 (1.60) | −6.10 to 0.22 | 0.068 | −0.29 |
| Prefer not to answer vs. Child | −7.55 (5.08) | −17.58 to 2.48 | 0.139 | −0.76 |
| Educational level | ||||
| Sencondary vs. Vocational training | 1.19 (2.07) | −2.91 to 5.29 | 0.567 | 0.12 |
| University vs. Vocational training | −4.96 (2.16) | −9.23 to −0.69 | 0.023* | −0.50 |
| Primary vs. Vocational training | 1.26 (2.53) | −3.74 to 6.26 | 0.618 | 0.13 |
| No formal education vs. Vocational training | 5.33 (4.78) | −4.12 to 14.78 | 0.267 | 0.53 |
| Previous children with bronchiolitis (Yes vs. No) |
4.24 (2.07) | 0.14 to 8.33 | 0.043* | 0.42 |
| Bronchiolitis in current child (Yes vs. No) |
−4.61 (1.81) | −8.19 to −1.03 | 0.012* | −0.46 |
| Hospitalization (Yes vs. No) | 0.81 (1.89) | −2.92 to 4.55 | 0.667 | 0.08 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).